Soon To Become A Reality- A Damaged Kidney Restoration
An event that hasn’t happened before was demonstrated by researchers from Duke-NUS Medical School, colleagues in Germany, and the National Heart Centre Singapore (NHCS),...
A New Healer Antibody Medicine For Fatty Liver Disease
Karolinska Institute researchers have come up with a promising antibody medication candidate for the medication of non-alcoholic fatty liver disease.
There is presently no treatment...
Clinical Trials Information System Now A Single Point Check
All initial clinical trial applications across the EU have to be submitted via the Clinical Trials Information System (CTIS) starting January 31, 2023.
As per...
Singapore Research & Innovation Gets A Push Of $50mn Funding
NUS Academic Medical Centre and SingHealth in Singapore have announced a gift of $50 million, which will be transformational, from the Lee Foundation that...
Cancer Spread Given More Thrust Because of Role of Actin
The University of Freiburg researchers have found out that the release of prometastatic factors is influenced by the skeleton of the cell, known as...
UK Into Thailand Genomic Collaboration On Health Threats
A new partnership with Thailand to share the expertise of genome sequencing, research collaboration, education and training opportunities, as well as genomics data handling...
Drug Nod Delays Not Hampering South Korean Pharma Position
According to a survey from Fitch Solutions, South Korea's pharmaceutical market attractiveness is expected to stay strong despite ongoing concerns about the country's slow...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...
























